Tag:
Iorcaserin
Latest Headlines
Latest Headlines
Arena shelves insomnia drug on trial failure
Shares of Arena Pharmaceuticals were dented after the developer announced that a Phase IIb trial of a new insomnia drug--APD125-- failed to hit its primary or secondary endpoints and will be shelved.
